KATHRYN CARPENTER: Open Payments
NPI 1932970209 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 44 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $160 · 2025 $1,183
Food & beverage: $1,183
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $322 |
| ABBVIE INC. | 8 | $269 |
| Mallinckrodt Hospital Products Inc. | 4 | $101 |
| Medical Device Business Services, Inc. | 1 | $72 |
| UCB, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| GENZYME CORPORATION | 2 | $49 |
| Janssen Biotech, Inc. | 3 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: RINVOQ, EVENITY, UPLIZNA, ACTHAR, STRATAFIX, Bimzelx, KEVZARA, TREMFYA.
Industry payments across FL — which companies pay providers there.
